Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
17.75
-0.01 (-0.06%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $759.72 million as of August 28, 2026. Its market cap has increased by 172.71% in one year.
Market Cap
759.72M
Enterprise Value
589.56M
1-Year Change
172.71%
Ranking
Category
Stock Price
$17.75
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $759.72M, an increase of 146.03%. That is a compound annual growth rate of 111.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 759.72M | 227.66% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 814.21M |
| Aura Biosciences | 808.90M |
| Oculis Holding AG | 800.66M |
| Silence Therapeutics | 798.94M |
| Obsidian Therapeutics | 797.20M |
| Shattuck Labs | 789.86M |
| Neurogene | 765.44M |
| Monopar Therapeutics | 765.19M |